338 related articles for article (PubMed ID: 10770189)
1. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
[TBL] [Abstract][Full Text] [Related]
2. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
[TBL] [Abstract][Full Text] [Related]
3. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males.
Wallace JD; Cuneo RC; Lundberg PA; Rosén T; Jørgensen JO; Longobardi S; Keay N; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
J Clin Endocrinol Metab; 2000 Jan; 85(1):124-33. PubMed ID: 10634375
[TBL] [Abstract][Full Text] [Related]
4. Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse.
Krusenstjerna-Hafstrøm T; Rasmussen MH; Raschke M; Govender S; Madsen J; Christiansen JS
Growth Horm IGF Res; 2011 Dec; 21(6):331-5. PubMed ID: 21963127
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
[TBL] [Abstract][Full Text] [Related]
7. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
9. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
Abrahamsen B; Hangaard J; Horn HC; Hansen TB; Gregersen G; Hansen-Nord M; Vahl N; Junker P; Andersen M; Hagen C
Clin Endocrinol (Oxf); 2002 Aug; 57(2):273-81. PubMed ID: 12153608
[TBL] [Abstract][Full Text] [Related]
11. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
12. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
13. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
Di Luigi L; Rigamonti AE; Agosti F; Mencarelli M; Sgrò P; Marazzi N; Cella SG; Müller EE; Sartorio A
Eur J Endocrinol; 2009 May; 160(5):753-8. PubMed ID: 19258430
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
Schou AJ; Heuck C; Wolthers OD
Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD
J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
[TBL] [Abstract][Full Text] [Related]
16. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
[TBL] [Abstract][Full Text] [Related]
17. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes.
Nelson AE; Meinhardt U; Hansen JL; Walker IH; Stone G; Howe CJ; Leung KC; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2008 Jun; 93(6):2213-22. PubMed ID: 18381573
[TBL] [Abstract][Full Text] [Related]
19. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
Shou Z; Jin X; Bian P; Li X; Chen J
Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
[TBL] [Abstract][Full Text] [Related]
20. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
